Abstract | AIMS: MATERIALS AND METHODS: Systematic literature searches were performed across PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and clinicaltrials.gov from 1966 to September 2018 to identify randomized, controlled trials. Mean difference (MD) or odds ratio (OR) was used to evaluate efficacy and safety end-points (active group vs control group), wherever appropriate. Heterogeneity was assessed by P value of χ2 statistics and I 2. RESULTS: CONCLUSIONS:
|
Authors | Hung-Wei Liao, Yi-Ling Wu, Yuh-Mou Sue, Meng Lee, Bruce Ovbiagele |
Journal | Endocrinology, diabetes & metabolism
(Endocrinol Diabetes Metab)
Vol. 2
Issue 1
Pg. e00050
(Jan 2019)
ISSN: 2398-9238 [Electronic] England |
PMID | 30815577
(Publication Type: Journal Article)
|